Casagrande et al., 2019 - Google Patents
Dopaminergic prodrugsCasagrande et al., 2019
- Document ID
- 8098931888365406103
- Author
- Casagrande C
- Santangelo F
- Publication year
- Publication venue
- Peripheral Dopamine Pathophysiology
External Links
Snippet
This chapter discusses the available information on ibopamine, rather than being as comprehensively reviewed as the other prodrugs. The usefulness of the prodrug approach to the purpose of improving the delivery and the effectiveness of drugs at their sites of action …
- 229940002612 prodrug 0 title abstract description 50
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014131716A (en) | STABLE PHARMACEUTICAL COMPOSITIONS AND WAYS OF THEIR APPLICATION | |
| US11478551B2 (en) | Long-acting adrenomedullin derivative | |
| EP1908461A1 (en) | Use of (1S, 2R) enantiomer of milnacipran for the preparation of a medicine | |
| JPH0649651B2 (en) | Pharmaceutical composition for treating myocardial ischemia | |
| FR2482093A1 (en) | NOVEL OYTOCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES | |
| CA2125776A1 (en) | Pharmaceutical composition and process for the preparation thereof | |
| Casagrande et al. | Dopaminergic prodrugs | |
| Henning et al. | Cocaethylene is as cardiotoxic as cocaine but is less toxic than cocaine plus ethanol | |
| FR3107897A1 (en) | MONONUCLEOTID NICOTINAMIDE DERIVATIVES | |
| CN113181160A (en) | Application of isothiocyanate compounds | |
| KR20080061431A (en) | Treatment of Hypertension and Diabetic Nephropathy with APD-Labosil Cylase Inhibitor | |
| Steiner et al. | 6 Hypoglycaemic Agents Which Do Not Release Insulin | |
| KR20210040837A (en) | Composition comprising PGI2-receptor agonist and method for preparing the same | |
| JP2769217B2 (en) | Long-acting compositions of propafenone and quinidine for the treatment of cardiac conditions | |
| US20140018426A1 (en) | Food or beverage composition fortified with thyronamines and/or thyronamine precursors | |
| WO2009091134A2 (en) | Pharmaceutical composition for sepsis and septic shock | |
| JP5269297B2 (en) | Composition for preventing and / or treating hypertension containing garlic component | |
| RU2663836C1 (en) | L-enantymer of 2-ethyl-6-methyl-3-hydroxypiridinium hydroxybutandioate possessing cerebroprotective activity | |
| S Dhaneshwar et al. | Prodrug strategies for antihypertensives | |
| KR100844190B1 (en) | Use of fibrate for the manufacture of a medicament useful for the treatment of congestive heart failure | |
| EP3353165B1 (en) | 1,4-di-(4-methylthiophenyl)-3-phtaloylazetidine-2-one and the derivatives thereof | |
| Gabriel et al. | Pharmacological activity of novel 2-hydroxyacetophenone isatin derivatives on cardiac and vascular smooth muscles in rats | |
| Bhimji et al. | Isoproterenol-induced myocardial ischemic injury in the rabbit: functional and ultrastructural alterations | |
| US20120041035A1 (en) | Levamlodipine compound pharmaceutical composition | |
| FR2586352A1 (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING UBIQUINONE-TYPE COENZYME, HAVING CARDIAC AND METABOLIC PROTECTION ACTIVITY ON MUSCLE ENERGETIC METABOLISM |